Related Experiment Videos
Family History and Clinical Severity of Functional Constipation: Sex-Stratified Findings from the FAMI-CON+
Akihiko Oka1, Kazuhiro Kozuka2, Koki Matsuo3
1Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo, Japan.
Insights
A family history of functional constipation (FC) is linked to earlier symptom onset and increased severity, particularly in women. These findings suggest genetic and environmental factors influence FC presentation.
Area of Science:
- Gastroenterology
- Genetics
- Epidemiology
Background:
- Functional constipation (FC) is a common gut-brain interaction disorder with limited research on adult risk factors.
- Prior studies suggest familial influences on FC prevalence and severity.
- Understanding these influences is crucial for managing FC and improving patient quality of life.
Purpose of the Study:
- To investigate the association between family history and the clinical phenotype of functional constipation in an adult cohort.
- To explore potential familial influences on disease onset and symptom severity using a standardized scoring system.
Main Methods:
- Retrospective multicenter study of 266 adults diagnosed with FC (Rome IV criteria).
- Data collected: family history, demographics, age at onset, modified Constipation Scoring System (mCSS) scores (pre/post-treatment), and medications.
- Analysis focused on associations between family history, age at onset, and mCSS scores.
Main Results:
- 30.1% of patients reported a family history of FC, more prevalent in women.
- In women, family history correlated with earlier onset (median 30 vs. 40 years) and higher baseline mCSS scores (median 11 vs. 8).
- Specific symptoms like incomplete evacuation were more pronounced in women with a family history; treatment response was similar across groups.
Conclusions:
- Family history is associated with sex-specific clinical presentations of FC.
- These sex differences may stem from interactions between genetic predisposition, hormonal factors, and shared family environments.
- Further research into these interactions can inform targeted FC management strategies.
Introduction:
Functional constipation (FC) is one of the most prevalent disorders of gut-brain interaction, associated with reduced quality of life and increased morbidity and mortality. Although several studies have examined risk factors in children, research focusing on adult populations is considerably limited. The present study investigated the association between family history and the clinical phenotype of FC using an adult cohort and a standardized constipation scoring system, building on prior population-based findings suggesting familial influences on disease prevalence and severity.
Methods:
A retrospective multicenter study of adults diagnosed with FC according to the Rome IV criteria was conducted at 9 Japanese centers. Collected data included family history, demographic characteristics, age at symptom onset, modified Constipation Scoring System (mCSS) scores before and after treatment, and prescribed medications, with onset age and mCSS selected to evaluate potential familial associations with earlier disease onset and greater symptom severity.
Results:
Data from 266 patients were analyzed. A family history was present in 30.1% of patients and was more common in women (34.5%) than in men (22.1%) (OR 1.86, 95% CI: 1.04-3.31; p = 0.037). Among the women, a positive family history was associated with earlier onset (median 30 vs. 40 years, p = 0.043) and higher baseline mCSS scores (median 11 vs. 8, p = 0.039), whereas no significant associations were observed in men. Subscore analyses showed higher ratings for "feeling of incomplete evacuation" and "minutes in lavatory per attempt" in women with a family history. Although women with a family history required more medications, treatment response, as measured by improvement in mCSS, was comparable to those without such history.
Conclusion:
Family history is associated with sex-specific differences in the clinical presentation of FC. This pattern may reflect interactions between genetic susceptibility, hormonal factors, and shared familial environments.
Related Concept Videos
01:25Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
01:21Drugs for Treatment of Constipation-Predominant IBS
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
01:17Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...